Publicacións nas que colabora con TOMAS M. M. GARCIA-CABALLERO PARADA (9)

2022

  1. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

    Frontiers in Pharmacology, Vol. 13

2020

  1. Author Correction: Identification and characterization of Cardiac Glycosides as senolytic compounds (Nature Communications, (2019), 10, 1, (4731), 10.1038/s41467-019-12888-x)

    Nature Communications

2019

  1. Context-Dependent Impact of RAS Oncogene Expression on Cellular Reprogramming to Pluripotency

    Stem Cell Reports, Vol. 12, Núm. 5, pp. 1099-1112

  2. Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats

    Biochemical Pharmacology, Vol. 170

  3. Identification and characterization of Cardiac Glycosides as senolytic compounds

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Adult Sox2+ stem cell exhaustion in mice results in cellular senescence and premature aging

    Aging Cell, Vol. 17, Núm. 5

  2. Pkd2 deletion during embryo development does not alter mesonephric programmed cell senescence

    International Journal of Developmental Biology, Vol. 62, Núm. 9-10, pp. 637-640

2016

  1. Cell senescence is an antiviral defense mechanism

    Scientific Reports, Vol. 6

2003

  1. Serotonin upregulates the activity of phagocytosis through 5-HT 1A receptors

    British Journal of Pharmacology, Vol. 139, Núm. 2, pp. 457-463